DexCom (DXCM) Tops Q3 EPS by 27c, Revenues Beat; Lifts FY18 Revenue Outlook Above Consensus

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. QGEN
5. NDAQ
6. QS
7. TXN
8. BRO
9. BFH
10. SAP

Go back to DexCom (DXCM) Tops Q3 EPS by 27c, Revenues Beat; Lifts FY18 Revenue Outlook Above Consensus

DexCom (DXCM) PT Raised to $150 at Oppenheimer

November 7, 2018 9:35 AM EST

Oppenheimer analyst Steven Lichtman raised the price target on DexCom (NASDAQ: DXCM) to $150.00 (from $125.00) while maintaining a Outperform rating.

The analyst commented, "DXCM's 3Q18 sales of $267M (+45% cc) beat our/consensus' $241/$243M, led by strong outperformance in International and better... More

DexCom (DXCM) PT Raised to $170 at Stephens

November 7, 2018 8:34 AM EST

Stephens analyst Chris Cooley raised the price target on DexCom (NASDAQ: DXCM) to $170.00 (from $160.00) while maintaining a Overweight rating following the company's 3Q report. Sales were in-line with Stephens' well-above consensus revenue estimate.

DXCM appears well positioned to continue to deliver... More